I

ImmunoMind.

15 employees

Multi-Omics Driven Development of Effective Cell Therapies

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Engineered TCR
Biotech
Artificial Intelligence
Immunogenomics
Adoptive T-cell therapy
Single-cell
Deep Learning
Single-cell transcriptomics
Immunology
Precision medicine
CAR-T
Therapeutics
Genetics
CAR-NKT
Bioinformatics

Date founded

2020

Funding rounds raised

Total raised

$105K

from 1 investors over 1 rounds

I

ImmunoMind. raised $105K on March 12, 2020

Investors: Berkeley SkyDeck

FAQ